Ticker: CO, Company: Global Cord Blood Corp, Type: 20-F, Date: 2018-07-23, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: CO/20180723/20-F/1/000.htm SEC Original: a18-11014_120f.htm
FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: Global Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 8180 albert.chen@globalcordbloodcorp.com 48 th Floor, Bank of China

---

---

Webplus: CO/20180723/20-F/2_EX-8.1/000.htm SEC Original: a18-11014_1ex8d1.htm
List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Ltd. People’s Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. People’s Republic of China Zhejiang Lukou Biotechnology Co., Ltd. People’s Republic of China China Stem Cells (East) Company Limited British Virgin Islands China Stem

---

---

Webplus: CO/20180723/20-F/3_EX-12.1/000.htm SEC Original: a18-11014_1ex12d1.htm
Certification I, Ting Zheng, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b. July 23, 2018 Ting Zheng Chief Executive Officer EX-12.1 3 a18-11014_1ex12d1.htm EX-12.1

---

---

Webplus: CO/20180723/20-F/4_EX-12.2/000.htm SEC Original: a18-11014_1ex12d2.htm
Certification I, Albert Chen, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b. July 23, 2018 Albert Chen Chief Financial Officer (Principal Financial Officer) EX-12.2 4 a18-11014_1ex12d2.htm EX-12.2

---

---

Webplus: CO/20180723/20-F/5_EX-13.1/000.htm SEC Original: a18-11014_1ex13d1.htm
Certification GLOBAL CORD BLOOD CORPORATION July 23, 2018 Ting Zheng Chief Executive Officer July 23, 2018 Albert Chen Chief Financial Officer (Principal Financial Officer) EX-13.1 5 a18-11014_1ex13d1.htm EX-13.1

---

---

Webplus: CO/20180723/20-F/6_EX-15.1/000.htm SEC Original: a18-11014_1ex15d1.htm
Consent of Independent Registered Public Accounting Firm The Board of Directors Global Cord Blood Corporation We consent to the incorporation by reference in the registration statements (No. 333 -183143 and No. 333 – 213730) on Form F-3 of Global Cord Blood Corporation (formerly known as China Cord Blood Corporation) of our reports dated July 23, 2018, with respect to the

---

---

Webplus: CO/20180723/20-F/7_EX-15.2/000.htm SEC Original: a18-11014_1ex15d2.htm
Global Cord Blood Corporation 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Madams and Sirs, Yours faithfully, Zhong Lun Law Firm EX-15.2 7 a18-11014_1ex15d2.htm EX-15.2

---

---

Webplus: CO/20180723/20-F/8_EX-15.3/000.htm SEC Original: a18-11014_1ex15d3.htm
E Scrip Dividend Scheme — June 2018 GLOBAL CORD BLOOD CORPORATION (NYSE:CO) DISCLAIMER Offering of Scrip Shares Table of Contents Page Summary 1 Terms of the Distribution 2

---

Company Info:

Ticker: CO, Company: Global Cord Blood Corp, Type: 20-F, Date: 2018-07-23, XBRL Interactive FinancialsCIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER, 1 GARDEN ROAD
CENTRAL HONG KONG, K3 000000